NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

Dec 22 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the ...

And one of them is pharmaceutical giant Pfizer (NYSE: PFE). Now, with a major step along the path to entering this ...

Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong ...

Pfizer is acquiring Metsera, a clinical-stage biopharmaceutical company with a focus on medicines for obesity and cardiometabolic diseases, in a deal valued at up to $7.3 billion. “Pfizer said it ...

AbbVie has a strong presence in immunology, oncology and neuroscience areas. Other than that, AbbVie also has products for ...